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Ensuring equal access to effective treat-
ments for individuals in equal need of
health care, regardless of their country of
origin, is a fundamental goal for any health
care system. The Spanish case is relevant
from a policy perspective, given that the
rapid increase in immigration has placed
important pressures on health expenditure
in a health system where virtually all the
population are legally entitled to free
access to health care. While a growing
body of literature in Spain has explored
whether, despite the universality of health
benefits, differences in health  status and in
the utilisation of health services exist
between immigrants and the Spanish pop-
ulation, differences in the consumption of
medications or self-medicated drug use
have received less attention. The common
practice in many countries of consuming
drugs without a medical prescription could
not only have important direct conse-
quences for the health of the individual but
also considerable unintended conse-
quences for the health of the population at
the community level, namely that an inad-
equate consumption of medications might
reduce drug resistance. In Spain both the
demand for and sale of drugs without the
need for a medical prescription is a rela-
tively frequent phenomenon. As a con-
sequence, the Spanish Ministry of Health
has now launched specific campaigns
aimed at improving the rational use of
medicines. 
The international context
The international literature, mainly from
the United States, provides evidence of sig-
nificant differences in the consumption of
pharmaceuticals by immigrant popula-
tions. For example, one study found that
Black or Hispanic users of Medicare
consume fewer pharmaceuticals than
White users with the same chronic illness
and pharmaceutical coverage. Another
important conclusion of this study is that
the type of pharmaceutical consumed by
ethnic minorities is also cheaper.1 More
recently, another US study confirmed these
results, showing that a large proportion of
the disparities in out-of-pocket expen-
diture and in the consumption and
expenditure in pharmaceuticals of White,
Black and Hispanic ethnic minorities are
not completely due to differences in pop-
ulation characteristics, such as the lower
socioeconomic status of minority groups,
but to factors related to the race or eth-
nicity of the individual.2 The authors
attribute ethnic inequalities in the con-
sumption of pharmaceuticals to the
scepticism of these patients with respect to
medicine and health care in general, lower
compliance with medical advice, commu-
nication problems with doctors and
possibly differences in physician pre-
scribing habits. 
The Spanish case
While there is a growing number of studies
in Spain that explore differences in health
and health care use between immigrants
and Spaniards, the literature on differences
in pharmaceutical consumption is limited.
One recent report shows that the (age–sex
adjusted) pharmaceutical spending of
immigrants is much lower than that of
their Spanish counterparts.3 The findings
of another study in the city of Lleida in
Catalonia suggest that both pharmaceutical
drug spending and drug consumption are
lower for non-Spanish-born individuals
relative to Spanish-born individuals of the
same age and sex4. Finally, one study using
data from the 2003 Spanish National
Health Survey also reaches similar conclu-
sions.5 However this study found no
significant difference between the Spanish
national and non-national populations in
self-medication patterns.
Another study has made use of the 2006
Spanish National Health Survey. This
survey includes a sufficiently large sample
of the foreign-born population.6 The use
of this survey allowed the authors to make
a detailed comparison of drug con-
sumption between Spaniards and several
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categories of immigrants, thus taking into
account the heterogeneity inherent to the
immigrant population living in Spain. The
analysis is based on a multilevel multin-
omial probit model that compares three
consumption options (no consumption of
drugs, consumption of prescribed drugs
and self-medicated consumption) for the
five most consumed drugs in Spain. Evi-
dence from this study suggests that there
are some important differences in pharma-
ceutical consumption linked to country of
birth. In particular, Africans, Europeans
(from non European Union countries) and
European Union individuals show a lower
probability of consuming prescription
medicines than Spaniards, while citizens
from the European Union and Africa also
show a higher probability of using no drug
treatment at all for the same level of need.
Interestingly, the results obtained by this
study reveal that for Romanian born cit-
izens the probability of consuming
medicines without a medical prescription
is higher than for Spanish born citizens,
while individuals born in the European
Union have a lower probability of self-
medication. 
While there are many factors that could
explain differences in prescribed con-
sumption and no consumption of
medicines,2 the observed disparities in pat-
terns of self-medication could be attributed
to cultural differences. This is because
according to one recent survey of nineteen
European countries, Romania has one of
the highest self-medication rates for
antimicrobial drugs, while other European
countries show lower self-medication rates
than Spain.7
Another important result from this study
is that there are factors, in addition to those
accounting for the effect of cost sharing,
such as health limitations and retirement
status, that are relevant in explaining drug
consumption in Spain. In particular, being
in receipt of private insurance is found to
be associated with a higher probability of
drug consumption, implying that the
actual cost sharing structure in Spain,
which is not means tested, may generate
inequalities in access to drugs, particularly
for poorer individuals who do not meet age
and disability criteria to be exempt from
co-payments.
Key conclusions
The rapid increase in the immigration phe-
nomenon in Spain has placed important
pressures on health care expenditure in a
health system where virtually all the pop-
ulation is legally entitled to free access to
health care. While there is a growing body
of research in Spain that analyses whether,
despite the universality of health benefits,
differences in health status and health care
access exist on the basis of the country of
origin of an individual, to date there is
limited evidence on the existence of differ-
ences in the consumption of prescription
medicines or self-medication.
According to the most recent empirical lit-
erature reviewed in this article, in Spain, as
in other countries with a longer tradition
as immigrant recipient countries such as
the United States, consumption of medi-
cines varies by country of birth. Overall,
immigrants tend to consume fewer phar-
maceuticals and are more likely not to have
any treatment at all compared to Spaniards
with the same illness and socioeconomic
characteristics. A small group of immi-
grants, however, tend to have higher self
medication rates than the Spanish popu-
lation, which all else being equal is
probably due to cultural factors. 
The differences in the use of health services
and in the consumption of medicines in
Spain suggest that the Spanish National
Health System has an important role to
play in the design of more effective health
services for immigrants. Policy proposals
have been put forward and discussed else-
where.8 Given the decentralisation of the
health system, it is expected that only those
regions with a higher proportion of immi-
grants in their total population will bring
forward measures to better integrate immi-
grant groups. 
However, the reduction in the foreign-
born population now being observed as a
consequence of the current economic
recession in Spain might reduce incentives
to adopt new measures to improve the
access of ethnic minorities to health
services. At the same time, if the arrival of
new immigrants decreases, it is likely that
the differences in pharmaceutical use
between established immigrants and the
native population will narrow significantly,
since most of the international evidence
suggests that disparities in the use of health
services tend to decrease with the number
of years in the recipient country. 
There is a wide scope for future research in
this area. Most of the limitations of studies
in this area are related to data availability.
If data become available, it would be very
interesting to explore whether divergences
in drug consumption really tend to reduce
with the number of years living in Spain.
Also, future studies may consider
exploring the links between disparities in
drug consumption related to country of
birth and inequalities in health, or in access
to medications, respectively.
REFERENCES
1. Briesacher BA, Limcangco R, Gaskin
DJ. Racial and ethnic disparities in 
prescription coverage and medication use.
Health Care Financing Review
2003;25(2):63–76. 
2. Gaskin DJ, Briesacher BA, Limcangco
R, Brigantti LB. Exploring racial and ethnic
disparities in prescription drug spending
and use among Medicare beneficiaries.
American Journal of Geriatric 
Pharmacotherapy 2006;4(2):96–111. 
3. Casado Marín D, Puig Junoy J, Puig
Peiró R. El impacto de la demografía sobre
el gasto sanitario futuro de las 
Comunidades Autónomas. [The impact of
demography on future health spending in
the Autonomous Communities] Madrid:
Fundación Pfizer, 2009. Available at
http://www.fundacionpfizer.org/docs/pdf/
publicaciones/documentos_trabajo/
Impacto_demografia_gasto_sanitario.pdf
4. Rue M, Serna MC, Soler-González J,
Bosch A, Ruiz-Magaz MC, Galvan L. 
Differences in pharmaceutical consumption
and expenses between immigrant and 
Spanish-born populations in Lleida,
(Spain): A 6-months prospective observa-
tional study. BMC Health Services 
Research 2008;8(35) 
5. Carrasco R, Jimeno JF, Ortega AC. Los
efectos de la inmigración sobre las condi-
ciones de los trabajadores nativos en el
mercado de trabajo: evidencia para España.
[The effect of immigration on the condition
of native workers in the labour market: 
evidence from Spain. In: Aja E, Arango J,
Oliver J (eds). La inmigración en la 
encrucijada. Anuario de la inmigración en 
España. [Immigration at the crossroads.
Yearbook of Immigration in Spain]
Barcelona: Cidob edicions, 2008
6. Jiménez-Rubio D, Hernández-Quevedo
C. Explaining the demand for pharmaceuti-
cals in Spain: are there differences in drug
consumption between foreigners and the
Spanish population? Health Policy
2010;97:217–24.
7. Grigoryan L et al. Self-medication with
antimicrobial drugs in Europe. Emerging
Infectious Disease 2006;12(3):452–59.
8. Hernández-Quevedo C, Jiménez-Rubio
D. New citizens, new challenges for the
Spanish National Health System, 
Eurohealth 2010;16(1):24 –25.
HEALTH POLICY DEVELOPMENTS
